Taken together, newly identified insights into the pharmacological effects of the MGAT2 inhibitor in this study further support the concept that pharmacological MGAT2 inhibition could be used as a treatment for obesity and its related metabolic diseases. The gene discussed is MGAT2; the disease is Other metabolic disease.